Characteristics of an outpatient treatment sample by primary substance of abuse.

Abstract:

OBJECTIVE:This study examines sociodemographic and clinical characteristics, as a function of primary substance of abuse, among clients approached, screened, and assessed for eligibility in a 10-site effectiveness trial of a Web-based psychosocial intervention for substance use disorders. Consistent with the design of effectiveness trials, eligibility criteria were broad and exclusion criteria minimal; thus, the recruited sample may be viewed as relatively representative of patients seeking treatment throughout the United States. METHODS:χ tests for categorical variables and F tests for continuous variables were used to analyze demographic, substance use, physical and mental health, and sexual risk data collected at screening and baseline; pairwise comparisons between primary substance subgroups for baseline data were conducted if the test statistic P value was 0.01 or less. RESULTS:Few participants expressed disinterest in the study at screening because of the computer-assisted intervention. A diverse sample of substance users completed baseline and were enrolled: 22.9% marijuana; 21.7% opiates; 20.9% alcohol; 20.5% cocaine; and 13.9% stimulants users. Marijuana users demonstrated the greatest differences across primary substances: they were younger, less likely to be married or attend 12-step meetings, and more likely to be in treatment as a result of criminal justice involvement. All patients, even marijuana users, reported comparable rates of co-occurring mental health disorders and sexual risk and substantial rates of polysubstance use disorders. CONCLUSIONS:Primary substance of abuse may be a less important indicator of overall severity compared with co-occurring disorders and other factors common across treatment seekers, further demonstrating the need for integrated treatment services and care and comprehensive pretreatment assessment.

journal_name

J Addict Med

authors

Campbell AN,Nunes EV,McClure EA,Hu MC,Turrigiano E,Goldman B,Stabile PQ

doi

10.1097/ADM.0b013e31829e3971

subject

Has Abstract

pub_date

2013-09-01 00:00:00

pages

363-71

issue

5

eissn

1932-0620

issn

1935-3227

pii

01271255-201309000-00009

journal_volume

7

pub_type

杂志文章
  • To Improve Substance Use Disorder Prevention, Treatment and Recovery: Engage the Family.

    abstract::: Approximately 21 million people in the United States have a substance use disorder (SUD); the number of family members impacted by a loved one's SUD is exponentially greater. Affected family members of individuals with SUDs are at high risk for developing chronic medical and psychiatric health conditions, are high u...

    journal_title:Journal of addiction medicine

    pub_type: 杂志文章

    doi:10.1097/ADM.0000000000000331

    authors: Ventura AS,Bagley SM

    更新日期:2017-09-01 00:00:00

  • Sex differences among opioid-abusing patients with chronic pain in a clinical trial.

    abstract:BACKGROUND:The characteristics of patients with co-occurring chronic pain and prescription opioid abuse have not been well described, and even less is known about differences between men and women in this population. OBJECTIVES:This study evaluated sex differences in the demographic, diagnostic, and behavioral attribu...

    journal_title:Journal of addiction medicine

    pub_type: 杂志文章

    doi:10.1097/ADM.0000000000000086

    authors: Manubay J,Davidson J,Vosburg S,Jones J,Comer S,Sullivan M

    更新日期:2015-01-01 00:00:00

  • Adverse Events During Treatment Induction With Injectable Diacetylmorphine and Hydromorphone for Opioid Use Disorder.

    abstract:OBJECTIVES:The present study aims to describe a 3-day induction protocol for injectable hydromorphone (HDM) and diacetylmorphine (DAM) used in 3 Canadian studies and examine rates of opioid-related overdose and somnolence during this induction phase. METHODS:The induction protocol and associated data on opioid-related...

    journal_title:Journal of addiction medicine

    pub_type: 杂志文章

    doi:10.1097/ADM.0000000000000505

    authors: Oviedo-Joekes E,Palis H,Guh D,Marsh DC,MacDonald S,Harrison S,Brissette S,Anis AH,Schechter MT

    更新日期:2019-09-01 00:00:00

  • Outcome Differences in Neonates Exposed In-Utero to Opioids Managed in the NICU Versus Pediatric Floor.

    abstract:OBJECTIVE:The aim of the study is to determine length of stay and length of treatment in infants with neonatal abstinence syndrome (NAS) in the neonatal intensive care unit (NICU) compared to those in the pediatric floor. METHODS:Retrospective cohort of infants ≥34 weeks gestation admitted with diagnosis of NAS at a s...

    journal_title:Journal of addiction medicine

    pub_type: 杂志文章

    doi:10.1097/ADM.0000000000000455

    authors: Lembeck AL,Tuttle D,Locke R,Lawler L,Jimenez P,Mackley A,Paul DA

    更新日期:2019-01-01 00:00:00

  • The Association Between Antenatal Maternal Self-reported Substance Use, Maternal Characteristics, and Obstetrical Variables.

    abstract:BACKGROUND:Substance use disorders during pregnancy are a concern both to the public and medical community, because the negative consequences can be detrimental to both mother and the fetus. The accurate identification of prenatal drug exposure is necessary to determine appropriate medical and psychosocial intervention...

    journal_title:Journal of addiction medicine

    pub_type: 杂志文章

    doi:10.1097/ADM.0000000000000521

    authors: Berra A,Kamo S,Mohnot S,Rosselot J,Suire A,Stafford J,Hagan J,Stafford I

    更新日期:2019-11-01 00:00:00

  • Correlates of prescription drug nonmedical use and problem use by adolescents.

    abstract:OBJECTIVES:: This study characterizes patterns and correlates of prescription drug nonmedical (PDNM) use and prescription drug problem (PDP) use among U.S. adolescents. METHODS:: Using the 2003 National Survey on Drug Use and Health (NSDUH), we estimated annual prevalence of PDNM and PDP use. We stratified prevalence ...

    journal_title:Journal of addiction medicine

    pub_type: 杂志文章

    doi:10.1097/ADM.0b013e31815b5590

    authors: Simoni-Wastila L,Yang HW,Lawler J

    更新日期:2008-03-01 00:00:00

  • Facilitating factors and barriers to the use of medications in publicly funded addiction treatment organizations.

    abstract:OBJECTIVES:Publicly funded addiction treatment organizations have been slow to adopt pharmacotherapies. Few studies have examined the organizational factors associated with adoption of different types of medication in this treatment sector. This study identifies organization-level facilitators and barriers to the use o...

    journal_title:Journal of addiction medicine

    pub_type: 杂志文章

    doi:10.1097/ADM.0b013e3181b41a32

    authors: Knudsen HK,Roman PM,Oser CB

    更新日期:2010-06-01 00:00:00

  • Prospective study of QTc changes among former opiate addicts since admission to methadone maintenance treatment: benzodiazepine risk.

    abstract:OBJECTIVES:To prospectively evaluate QTc changes among methadone maintenance treatment (MMT) patients. METHODS:All 512 opiate addicts newly admitted to 2 MMT clinics had been prospectively studied for 4.5 years. Ninety-one patients were excluded because they were admitted from other MMTs, and 26 were excluded because ...

    journal_title:Journal of addiction medicine

    pub_type: 杂志文章

    doi:10.1097/ADM.0b013e3182a8a4f2

    authors: Peles E,Linzy S,Kreek MJ,Adelson M

    更新日期:2013-11-01 00:00:00

  • Provider Continuity in the Prescribing of Buprenorphine/Naloxone Within Medicare Part D.

    abstract:OBJECTIVES:Efforts to improve buprenorphine access for opioid use disorder have focused on increasing the number of waivered providers. However, it is unknown how efforts to increase initial prescribing result in a sustained pool of prescribers. We examine the prevalence of year-to-year provider-level buprenorphine pre...

    journal_title:Journal of addiction medicine

    pub_type: 杂志文章

    doi:10.1097/ADM.0000000000000765

    authors: Strickland JC,Huhn AS,Bergeria CL,Strain EC,Dunn KE

    更新日期:2020-11-03 00:00:00

  • HIV-risk characteristics in community corrections.

    abstract:OBJECTIVE:Individuals in the criminal justice system engage in behaviors that put them at high risk for HIV. This study sought to identify characteristics of individuals who are under community corrections supervision (eg, probation) and at risk for HIV. METHODS:Approximately 25,000 individuals under community correct...

    journal_title:Journal of addiction medicine

    pub_type: 杂志文章

    doi:10.1097/ADM.0b013e3182781806

    authors: Clark CB,McCullumsmith CB,Waesche MC,Islam MA,Francis R,Cropsey KL

    更新日期:2013-01-01 00:00:00

  • "Compassionate coercion": factors associated with court-mandated drug and alcohol treatment in pregnancy 1994-2005.

    abstract:OBJECTIVES:: To describe trends in court-mandated treatment in pregnancy. In particular, to determine whether pregnant women who enter treatment via the criminal justice system differ from women who enter voluntarily. METHODS:: Data were obtained from the Treatment Episode Data Set, an administrative data set that cap...

    journal_title:Journal of addiction medicine

    pub_type: 杂志文章

    doi:10.1097/ADM.0b013e3181b562dc

    authors: Terplan M,Smith EJ,Kozloski MJ,Pollack HA

    更新日期:2010-09-01 00:00:00

  • Development and implementation of an opioid overdose prevention program within a preexisting substance use disorders treatment center.

    abstract::This case study of the development and implementation of an opioid overdose prevention program is based on an actual clinic's experience, but information about the clinic, including details of implementation and outcome measures, has been changed. Four experts reflect on the medical, administrative, peer-support, comm...

    journal_title:Journal of addiction medicine

    pub_type: 杂志文章

    doi:10.1097/ADM.0000000000000032

    authors: Wilder CM,Brason FW 2nd,Clark AK,Galanter M,Walley AY,Winstanley EL

    更新日期:2014-05-01 00:00:00

  • Medications for Opioid use Disorder Associated With Less Against Medical Advice Discharge Among Persons Who Inject Drugs Hospitalized With an Invasive Infection.

    abstract:OBJECTIVES:To identify the incidence, characteristics, and factors associated with against medical advice (AMA) discharge among hospitalized patients with opioid use disorder (OUD) and injection related infections (eg, endocarditis, osteomyelitis, epidural abscesses). METHODS:This retrospective cohort study evaluated ...

    journal_title:Journal of addiction medicine

    pub_type: 杂志文章

    doi:10.1097/ADM.0000000000000725

    authors: Nolan NS,Marks LR,Liang SY,Durkin MJ

    更新日期:2020-08-14 00:00:00

  • Adaptation of a System of Treatment for Substance Use Disorders During the COVID-19 Pandemic.

    abstract::: The Grayken Center for Addiction at Boston Medical Center includes programs across the care continuum for people with substance use disorders (SUDs), serving both inpatients and outpatients. These programs had to innovate quickly during the COVID-19 outbreak to maintain access to care. Federal and state regulatory f...

    journal_title:Journal of addiction medicine

    pub_type: 杂志文章

    doi:10.1097/ADM.0000000000000791

    authors: Komaromy M,Tomanovich M,Taylor JL,Ruiz-Mercado G,Kimmel SD,Bagley SM,Saia KM,Costello E,Park TW,LaBelle C,Weinstein Z,Walley AY

    更新日期:2020-12-08 00:00:00

  • Epidemiology, clinical data, and treatment of viral hepatitis in a large cohort of intravenous drug users.

    abstract:OBJECTIVES:The aim of this study was to evaluate retrospectively the prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection, epidemiological parameters, and the clinical data from the antiviral treatment of hepatitis C in a large cohort of intravenous drug users (IDUs) followed-up from 1994 until 2...

    journal_title:Journal of addiction medicine

    pub_type: 杂志文章

    doi:10.1097/ADM.0b013e318279756f

    authors: Gigi E,Sinakos E,Sykja A,Androulakis G,Tanis C,Stayridou V,Tsirogianni E,Zouridakis K,Bellou AL,Orfanou E,Raptopoulou-Gigi M

    更新日期:2013-01-01 00:00:00

  • American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use.

    abstract::The Centers for Disease Control have recently described opioid use and resultant deaths as an epidemic. At this point in time, treating this disease well with medication requires skill and time that are not generally available to primary care doctors in most practice models. Suboptimal treatment has likely contributed...

    journal_title:Journal of addiction medicine

    pub_type: 杂志文章,实务指引

    doi:10.1097/ADM.0000000000000166

    authors: Kampman K,Jarvis M

    更新日期:2015-09-01 00:00:00

  • Hospital-based Buprenorphine Micro-dose Initiation.

    abstract::: Buprenorphine induction can be challenging for patients with chronic pain or patients who are unable to cease opioids for sufficient time to prevent precipitated opioid withdrawal. In the outpatient setting, low-dose buprenorphine induction strategies have been described to avoid these barriers; however, these strat...

    journal_title:Journal of addiction medicine

    pub_type: 杂志文章

    doi:10.1097/ADM.0000000000000745

    authors: Weimer MB,Guerra M,Morrow G,Adams K

    更新日期:2020-09-21 00:00:00

  • Co-occurring Substance Use Disorders in Youth With Chronic Medical Conditions: The Need for Integration of Addiction Treatment into Mainstream Medical Facilities.

    abstract::: Approximately 5% of adolescents in the US meet criteria for a substance use disorder (SUD), and many of them benefit from residential treatment programs at points in the course of the disorder to achieve early sobriety and stabilization. Youth with chronic medical conditions use alcohol, marijuana, and other substan...

    journal_title:Journal of addiction medicine

    pub_type: 杂志文章

    doi:10.1097/ADM.0000000000000557

    authors: Chadi N,Schizer M,Mountain-Ray S,Thakur A,Weitzman ER,Levy S

    更新日期:2020-05-01 00:00:00

  • Use of conventional, complementary, and alternative treatments for pain among individuals seeking primary care treatment with buprenorphine-naloxone.

    abstract:UNLABELLED:Previous studies have not examined patterns of pain treatment use among patients seeking office-based buprenorphine-naloxone treatment (BNT) for opioid dependence. OBJECTIVES:To examine, among individuals with pain seeking BNT for opioid dependence, the use of pain treatment modalities, perceived efficacy o...

    journal_title:Journal of addiction medicine

    pub_type: 杂志文章

    doi:10.1097/ADM.0b013e31826d1df3

    authors: Barry DT,Savant JD,Beitel M,Cutter CJ,Moore BA,Schottenfeld RS,Fiellin DA

    更新日期:2012-12-01 00:00:00

  • Onset of cocaine use: associated alcohol intoxication and psychosocial characteristics among adolescents in substance abuse treatment.

    abstract:OBJECTIVES:Cocaine abuse is widespread in Europe, and Ireland ranks among the leading countries for prevalence of cocaine use among adolescents. This study aimed to examine demographic and substance use correlates of lifetime cocaine use among adolescents with substance use disorder, and to explore the relationship bet...

    journal_title:Journal of addiction medicine

    pub_type: 杂志文章

    doi:10.1097/ADM.0b013e318288daa2

    authors: Apantaku-Olajide T,Darker CD,Smyth BP

    更新日期:2013-05-01 00:00:00

  • The feasibility and acceptability of groups for pain management in methadone maintenance treatment.

    abstract:OBJECTIVES:Effective and safe pain management interventions in methadone maintenance treatment are needed. METHODS:We examined the feasibility (ie, single-session attendance) and acceptability (ie, patient satisfaction and booster session attendance) of cognitive-behavioral therapy-informed groups for pain management-...

    journal_title:Journal of addiction medicine

    pub_type: 杂志文章

    doi:10.1097/ADM.0000000000000055

    authors: Barry DT,Savant JD,Beitel M,Cutter CJ,Schottenfeld RS,Kerns RD,Moore BA,Oberleitner L,Joy MT,Keneally N,Liong C,Carroll KM

    更新日期:2014-09-01 00:00:00

  • Non-medical Use of Naphazoline (Naphthyzin): Two Case Reports.

    abstract::: The paper describes 2 case reports of non-medical use of Naphazoline (Naphthyzin). Both demonstrate that the peripherally acting alpha-adrenergic agonist Naphazoline obtains some addictive potential. The drug produces a feeling of euphoria, which resembles the perceived effects of psychostimulants. Both patients and...

    journal_title:Journal of addiction medicine

    pub_type: 杂志文章

    doi:10.1097/ADM.0000000000000617

    authors: Skryabin VY,Vinnikova MA,Komarov SD,Khvan AG

    更新日期:2020-09-01 00:00:00

  • Synthetic Cannabis Analogues and Suicidal Behavior: Case Report.

    abstract:INTRODUCTION:Despite growing legal control, a wide range of synthetic cannabis analogues is currently used for recreational purposes, notwithstanding their well adverse outcomes, which appear to be more frequent and more serious than those associated with cannabis use. We present the case report of a patient with paran...

    journal_title:Journal of addiction medicine

    pub_type: 杂志文章

    doi:10.1097/ADM.0000000000000335

    authors: Oliveira PMDS,Morais ASF,Madeira NGGF

    更新日期:2017-09-01 00:00:00

  • Reward sensitivity, decisional bias, and metacognitive deficits in cocaine drug addiction.

    abstract:OBJECTIVES:The present research explored the effect of reward sensitivity bias and metacognitive deficits on substance use disorder (SUD) in the decision-making process. METHODS:The behavioral activation system (BAS) was used as a predictive marker of dysfunctional behavior during the Iowa gambling task (IGT). We also...

    journal_title:Journal of addiction medicine

    pub_type: 杂志文章

    doi:10.1097/ADM.0000000000000065

    authors: Balconi M,Finocchiaro R,Campanella S

    更新日期:2014-11-01 00:00:00

  • Rapid Micro-induction of Buprenorphine/Naloxone for Opioid Use Disorder in a Critically ill Intubated Patient: A Case Report.

    abstract:BACKGROUND:Buprenorphine/naloxone has been shown to be an effective treatment of opioid use disorder. According to the Canadian National clinical practice guideline on the management of opioid use disorders, given the superior safety profile of buprenorphine/naloxone and its potential for flexible take-home dosing in c...

    journal_title:Journal of addiction medicine

    pub_type: 杂志文章

    doi:10.1097/ADM.0000000000000675

    authors: Hamata B,Griesdale D,Hann J,Rezazadeh-Azar P

    更新日期:2020-12-01 00:00:00

  • Referral to Treatment After Positive Screens for Unhealthy Drug Use in an Outpatient Veterans Administration Setting.

    abstract:OBJECTIVES:To measure the rates and predictors of clinician recommendation for follow-up after a positive screen for unhealthy drug use, in a context of mandatory routine screening. To measure response to clinician recommendations and identification of new drug use diagnoses. METHODS:Data are from a Veterans Health Ad...

    journal_title:Journal of addiction medicine

    pub_type: 杂志文章

    doi:10.1097/ADM.0000000000000567

    authors: Hodgkin D,Gao W,Larson MJ,Drebing CE,Merrick EL,Pugatch M,Horgan CM,Zolotusky G,Petry NM,Saitz R

    更新日期:2020-05-01 00:00:00

  • An Argument for Change in Tobacco Treatment Options Guided by the ASAM Criteria for Patient Placement.

    abstract::Tobacco use is a major threat to public health in the United States, and the number one cause of preventable death. Although most smokers try to quit unaided, robust data indicate that pairing behavioral support to US Food Drug Administration-approved cessation medications significantly increase cessation rates. Those...

    journal_title:Journal of addiction medicine

    pub_type: 杂志文章,评审

    doi:10.1097/ADM.0000000000000239

    authors: Williams JM,Steinberg ML,Kenefake AN,Burke MV

    更新日期:2016-09-01 00:00:00

  • Combined abuse of clonidine and amitriptyline in a patient on buprenorphine maintenance treatment.

    abstract::Buprenorphine/naloxone maintenance therapy is often prescribed in primary care to treat opioid dependence. Previous reports have described concomitant abuse of opioids and clonidine. In this case, a primary care patient on buprenorphine/naloxone maintenance therapy demonstrating altered mental status, hallucinations, ...

    journal_title:Journal of addiction medicine

    pub_type: 杂志文章

    doi:10.1097/ADM.0000000000000081

    authors: Seale JP,Dittmer T,Sigman EJ,Clemons H,Johnson JA

    更新日期:2014-11-01 00:00:00

  • Validation of the NIDA-modified ASSIST as a Screening Tool for Prenatal Drug Use in an Urban Setting in the United States.

    abstract:BACKGROUND:Screening for prenatal drug use is recommended. The NIDA-modified Alcohol, Smoking, and Substance Involvement Screening Test (NM-ASSIST) is a screener for drug use that has not yet been validated with pregnant women. This study aims to assess the substance-specific diagnostic validity of the NM-ASSIST (not i...

    journal_title:Journal of addiction medicine

    pub_type: 杂志文章

    doi:10.1097/ADM.0000000000000614

    authors: Oga EA,Mark K,Peters EN,Coleman-Cowger VH

    更新日期:2020-09-01 00:00:00

  • Evaluation of quetiapine abuse and misuse reported to poison centers.

    abstract:OBJECTIVE:There are case reports of abuse of quetiapine, but no studies address quetiapine abuse or misuse. Most literature on the population that abuses quetiapine describes an older age group with previous substance abuse history, many of whom are in jail. The objective of this study was to evaluate national poison c...

    journal_title:Journal of addiction medicine

    pub_type: 杂志文章

    doi:10.1097/ADM.0000000000000020

    authors: Klein-Schwartz W,Schwartz EK,Anderson BD

    更新日期:2014-05-01 00:00:00